Visioneering Technologies, Inc.
Industry
- Medical Devices
See more in Biomedtracker
Latest on Visioneering Technologies, Inc.
In Vivo
• By Regina Paleski
Company Changes ADENT , John To: Neogen Corp. , CEO (July) From: Animal Health International, CEO Phone: 517-372-9200 ARENA , Paul To: Parallax Health Sciences Inc. , CEO (July) From: Arena
In Vivo
• By Amanda Micklus and Maureen Riordan
Device Transactions Financing by device companies in the first quarter of 2017 totaled $2.3 billion, slightly lower than Q4 2016's $2.4 billion. Notably, early-stage venture capital fundraising made u
In Vivo
IN VITRO DIAGNOSTICS Financings Biocept Inc. Biocept Inc. (blood-based molecular diagnostics for solid tumors) netted $8.7mm through the sale of 4.3mm common shares at $2.15 (a slight discount) to